Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
In BriefThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine November 2018, 59 (11) 10A;
  • Article
  • Info & Metrics
  • PDF
Loading

Network-linked neurodegenerative patterns: Drzezga looks at growing evidence that neurodegenerative disorders are characterized by the spread of specific molecular neuropathologic features along neuronal brain networks and examines associated imaging techniques, network overlaps, and potential causative relationships.

Page 1645

Interventional oncology and the liver: Voutsinas and colleagues provide an educational overview of indications for 90Y radioembolization, the roles of preprocedural angiography and 99mTc-macroaggregated albumin scans, different dosing techniques, types of microspheres, and potential complications.

Page 1649

43,44Sc, 52Mn, and 45Ti: Chaple and Lapi describe the characteristics of these emerging metal radionuclides and their potential as new PET agents.

Page 1655

PET and cerebral small vessel disease: Heiss details the advantages of functional information from the addition of 18F-FDG PET to current diagnostic imaging in cerebral small vessel disease, including differentiation of vascular and degenerative cognitive impairment.

Page 1660

NaF and PSMA PET/CT: Harmon and colleagues compare the diagnostic performance of 18F-DCFBC, a first-generation prostate-specific membrane antigen (PSMA)–targeted agent, and 18F-NaF, a sensitive marker of osteoblastic activity, in PET/CT imaging in patients with metastatic prostate cancer.

Page 1665

11C-Choline dynamic PET in PCa: Grkovski and colleagues investigate the value of pharmacokinetic modeling for quantifying 11C-choline uptake in patients with clinically suspected recurrent prostate cancer.

Page 1672

ανβ6 integrin–binding peptides: Roesch and colleagues analyze the affinity and specificity of 5 native ανβ6 integrin–specific binders in comparison to SFITGv6, a novel potential tracer for imaging and targeted therapy of ανβ6 integrin–positive carcinomas.

Page 1679

c-Met–targeted imaging: Han and colleagues report on preclinical studies with 99mTc-HYNIC-cMBP, a c-Met–binding peptide radiotracer for SPECT imaging, with promise for clinical selection and monitoring of non–small cell lung cancer for c-Met–responsive therapy.

Page 1686

90Y-DOTATOC dosimetry: Menda and colleagues describe a dosimetric method for 90Y-DOTATOC using 90Y-DOTATOC PET/CT and bremsstrahlung SPECT/CT and determine whether dosimetry-based administered activities differ significantly from standard doses.

Page 1692

PRRT with 177Lu-DOTA-EB-TATE: Zhang and colleagues present the results of a first-in-human study exploring the safety and dosimetry of this long-acting radiolabeled somatostatin analog with promise for peptide receptor radionuclide therapy for neuroendocrine tumors.

Page 1699

Radiopharmaceutical therapy now: Divgi offers perspective on the importance of broad clinical rigor in radiopharmaceutical clinical practice and previews an article in this issue of JNM on 131I-MIBG for metastatic neuroendocrine tumors.

Page 1706

Survival after 131I-MIBG therapy: Kane and colleagues provide a retrospective analysis identifying predictors of survival in patients with MIBG–positive stage IV pulmonary and gastroenteropancreatic neuroendocrine tumors treated with 131I-MIBG therapy.

Page 1708

68Ga-PSMA-11 PET/CT for RT planning: Calais and colleagues determine how often definitive radiation treatment planning based on standard target volumes covers 68Ga-PSMA-11 PET/CT–defined disease and assess the potential impact of 68Ga-PSMA-11 PET/CT on definitive planning.

Page 1714

PET in Huntington disease: Bertoglio and colleagues use 11C-ABP688 PET imaging to longitudinally characterize in vivo changes in metabotropic glutamate receptor 5 in a mouse model of Huntington disease.

Page 1722

123I-MIBG scintigraphy and wearing-off in PD: Lee and colleagues investigate whether cardiac sympathetic denervation increases the risk of the early wearing-off phenomenon in Parkinson disease.

Page 1728

PET/CT in cyst infection in ADPKD: Pijl and colleagues assess the value of 18F-FDG PET/CT for diagnosing renal or hepatic cyst infection in patients with autosomal dominant polycystic kidney disease.

Page 1734

Cost and bone SPECT/CT in TKA: Wyngaert and colleagues quantify the economic value of bone SPECT/CT and CT or metal artifact reduction–sequence MR imaging for diagnostic assessment of recurrent moderate-to-severe pain after total knee arthroplasty.

Page 1742

124I-DPA-713 PET/CT clinical studies: Foss and colleagues detail biodistribution and radiation dosimetry of this radioligand for the 18-kDa translocator protein in healthy individuals and discuss its potential in imaging of macrophage-associated inflammation.

Page 1751

Multispectral surgical guidance: Meershoek and colleagues describe preclinical studies with a multispectral fluorescence guidance approach that enables discrimination between prostate-draining and lower-limb–draining lymph nodes in prostate cancer surgery.

Page 1757

Rebinner with rigid motion correction: Reilhac and colleagues implement an accurate list-mode–based rigid motion correction method for PET data acquired with the mMR synchronous PET/MR scanner and optimize correction for 11C-Pittsburgh compound B scans

Page 1761

PET spatial resolution: Lodge and colleagues introduce a technique that can be used to measure the spatial resolution that can be expected with clinical PET protocols, potentially providing more relevant estimates than are typically obtained with established experimental procedures.

Page 1768

  • © 2018 by the Society of Nuclear Medicine and Molecular Imaging.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 59 (11)
Journal of Nuclear Medicine
Vol. 59, Issue 11
November 1, 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Nov 2018, 59 (11) 10A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Nov 2018, 59 (11) 10A;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • A Prospective Comparison of 18F-Sodium Fluoride PET/CT and PSMA-Targeted 18F-DCFBC PET/CT in Metastatic Prostate Cancer
  • 90Y-DOTATOC Dosimetry–Based Personalized Peptide Receptor Radionuclide Therapy
  • Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors
  • The Current State of Radiopharmaceutical Therapy
  • Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer
  • Longitudinal Characterization of mGluR5 Using 11C-ABP688 PET Imaging in the Q175 Mouse Model of Huntington Disease
  • 11C-Choline Pharmacokinetics in Recurrent Prostate Cancer
  • Predictors of Survival in 211 Patients with Stage IV Pulmonary and Gastroenteropancreatic MIBG-Positive Neuroendocrine Tumors Treated with 131I-MIBG
  • 18F-FDG PET/CT in Autosomal Dominant Polycystic Kidney Disease Patients with Suspected Cyst Infection
  • Biodistribution and Radiation Dosimetry of 124I-DPA-713, a PET Radiotracer for Macrophage-Associated Inflammation
  • Cardiac Sympathetic Denervation Can Predict the Wearing-off Phenomenon in Patients with Parkinson Disease
  • The Network Degeneration Hypothesis: Spread of Neurodegenerative Patterns Along Neuronal Brain Networks
  • Multispectral-Fluorescence Imaging as a Tool to Separate Healthy from Disease-Related Lymphatic Anatomy During Robot-Assisted Laparoscopy
  • The Additional Value of PET in the Assessment of Cerebral Small Vessel Disease
  • Cost-Effectiveness of Bone SPECT/CT in Painful Total Knee Arthroplasty
  • Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non–Small Cell Lung Cancer
  • Treatment of Primary Liver Tumors and Liver Metastases, Part 1: Nuclear Medicine Techniques
  • Development of a Dedicated Rebinner with Rigid Motion Correction for the mMR PET/MR Scanner, and Validation in a Large Cohort of 11C-PIB Scans
  • Measuring PET Spatial Resolution Using a Cylinder Phantom Positioned at an Oblique Angle
  • Production and Use of the First-Row Transition Metal PET Radionuclides 43,44Sc, 52Mn, and 45Ti
  • Comparison of the RGD Motif–Containing αvβ6 Integrin–Binding Peptides SFLAP3 and SFITGv6 for Diagnostic Application in HNSCC
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire